ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2017 Pediatric Rheumatology Symposium

May 17-20, 2017. Houston, Texas.

View by Number View by Title View Sessions
View by Date

Saturday, May 20, 2017

2:30PM-3:00PM
Abstract Number: 9
Biologically-Based Approach for Classifying Chronic Childhood Arthritis
Plenary Abstract Session 3
2:30PM-3:00PM
Abstract Number: 10
Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88
Plenary Abstract Session 3
5:15PM-5:45PM
Abstract Number: 33
An extracellular ionic milieu renders human granulocytic S100A12 into a pro-inflammatory TLR4-binding alarmin
Genetics and Pathogenesis Poster Breakout II
5:15PM-5:45PM
Abstract Number: 27
Assessing the Safety of Kidney Biopsies Performed on Childhood-onset Systemic Lupus Erythmatosus Patients
Clinical and Therapeutic Poster Breakout II
5:15PM-5:45PM
Abstract Number: 30
Cross-sectional Analysis of Depression and Medication Non-Adherence in Childhood-onset Systemic Lupus Erythematosus
Clinical and Therapeutic Poster Breakout II
5:15PM-5:45PM
Abstract Number: 28
Dyslipidemia in Juvenile Dermatomyositis
Clinical and Therapeutic Poster Breakout II
5:15PM-5:45PM
Abstract Number: 26
Gray Matter Volume Loss in Youth with SLE
Clinical and Therapeutic Poster Breakout II
5:15PM-5:45PM
Abstract Number: 32
High Mobility Group Box 1 Protein in Children with Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis
Genetics and Pathogenesis Poster Breakout II
5:15PM-5:45PM
Abstract Number: 37
Increased Involvement of Teenagers with Juvenile Idiopathic Arthritis in Treatment Decisions Using Medication Choice Cards: Preliminary Report from a Case-Control Study
Quality, Health Services and Education Research Poster Breakout II
5:15PM-5:45PM
Abstract Number: 38
Knowledge Translation in Juvenile Idiopathic Arthritis Research in Canada: A Focus on Pediatric Rheumatologists and Allied Health Professionals
Quality, Health Services and Education Research Poster Breakout II
5:15PM-5:45PM
Abstract Number: 35
Kv1.3 Expression on Urinary Leukocytes in Lupus Nephritis:  Potential for Targeted Immunotherapy
Genetics and Pathogenesis Poster Breakout II
5:15PM-5:45PM
Abstract Number: 40
Perspectives of young people with Juvenile Idiopathic Arthritis, their caregivers, and health care providers on transition to adult care: Informing development of a transition toolkit
Quality, Health Services and Education Research Poster Breakout II
5:15PM-5:45PM
Abstract Number: 31
Predicting therapy response to IL-1 blockade in systemic JIA: a biomarker search
Genetics and Pathogenesis Poster Breakout II
5:15PM-5:45PM
Abstract Number: 39
Rheumapalooza:  A rheumatology curriculum in evolution
Quality, Health Services and Education Research Poster Breakout II
5:15PM-5:45PM
Abstract Number: 29
Spinal Cord Inflammation in Children with Small Vessel Primary CNS Vasculitis
Clinical and Therapeutic Poster Breakout II
  • 1
  • 2
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology